Related Experiment Video
Updated: Jul 22, 2026

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section
Waleed Alhazzani1, Mohammed Alshahrani2, Fayez Alshamsi3
1Department of Medicine, McMaster University, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Canada; GUIDE Center, St. Joseph's Healthcare Hamilton, Hamilton, Canada.
Insights
Saudi experts developed evidence-based recommendations for managing severe COVID-19 in intensive care units (ICUs). The guidelines cover pharmacotherapeutic interventions, including immunomodulators and antivirals, to improve patient outcomes.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Clinical Pharmacy
Background:
- Rising COVID-19 cases necessitated expert guidance for intensive care unit (ICU) management.
- The Saudi Critical Care Society (SCCS) convened a panel to address critical care challenges during COVID-19 waves.
Purpose of the Study:
- To develop evidence-based recommendations for the therapeutic management of severe and critical COVID-19 in the ICU.
- To provide a framework for adapting treatment strategies based on evolving evidence.
Main Methods:
- A panel of 51 multidisciplinary experts was assembled.
- The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach and evidence-to-decision (EtD) framework were utilized.
- Systematic reviews and clinical trials were assessed to formulate recommendations.
Main Results:
- Twelve recommendations were issued for pharmacotherapeutic interventions in severe/critical COVID-19.
- Recommendations included immunomodulators, antiviral agents, and anticoagulants.
- Three strong and nine weak recommendations were provided.
Conclusions:
- The SCCS COVID-19 panel successfully formulated ICU management recommendations using the GRADE and EtD frameworks.
- The guidelines are adaptable to different healthcare settings.
- Recommendations will be updated as new evidence emerges.
Background:
The rapid increase in coronavirus disease 2019 (COVID-19) cases during the subsequent waves in Saudi Arabia and other countries prompted the Saudi Critical Care Society (SCCS) to put together a panel of experts to issue evidence-based recommendations for the management of COVID-19 in the intensive care unit (ICU).
Methods:
The SCCS COVID-19 panel included 51 experts with expertise in critical care, respirology, infectious disease, epidemiology, emergency medicine, clinical pharmacy, nursing, respiratory therapy, methodology, and health policy. All members completed an electronic conflict of interest disclosure form. The panel addressed 9 questions that are related to the therapy of COVID-19 in the ICU. We identified relevant systematic reviews and clinical trials, then used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach as well as the evidence-to-decision framework (EtD) to assess the quality of evidence and generate recommendations.
Results:
The SCCS COVID-19 panel issued 12 recommendations on pharmacotherapeutic interventions (immunomodulators, antiviral agents, and anticoagulants) for severe and critical COVID-19, of which 3 were strong recommendations and 9 were weak recommendations.
Conclusion:
The SCCS COVID-19 panel used the GRADE approach to formulate recommendations on therapy for COVID-19 in the ICU. The EtD framework allows adaptation of these recommendations in different contexts. The SCCS guideline committee will update recommendations as new evidence becomes available.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
04:43COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Acute Kidney Injury VI: Nursing Management